- $37.42bn
- $42.00bn
- $36.80bn
- 65
- 72
- 20
- 52
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 9.39 | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | -2.49% | ||
| Dividend Yield (f) | 1.34% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.54 | ||
| Price to Tang. Book | 1.55 | ||
| Price to Free Cashflow | 13.71 | ||
| Price to Sales | 1.06 | ||
| EV to EBITDA | 7.27 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 15.93% | ||
| Return on Equity | 17.83% | ||
| Operating Margin | 16.1% | ||
Financial Summary
| Year End 30th Sep | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 20,311.1 | 27,774.2 | 33,480 | 35,460.4 | 36,801.4 | 35,381.16 | 37,065.98 | 15.91% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +47.83 | +81.06 | +44.97 | -15.87 | +3.38 | -15.64 | +10.24 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
D.R. Horton, Inc. is a homebuilding company. The Company constructs and sells homes through its operating divisions in 125 markets across 36 states. The Company’s segments include Homebuilding, Rental, Forestar, Financial Services, and Other. The Homebuilding divisions are primarily engaged in the acquisition and development of land and the construction and sale of residential homes. The Company’s rental segment consists of single-family and multifamily rental operations. The single-family rental operations construct and lease single-family homes within a community and then generally market each community for a bulk sale of rental homes. The Forestar segment is a residential lot development company with operations in 59 markets across 24 states. The Financial services segment provides mortgage financing and title agency services to homebuyers in many of the Company’s homebuilding markets. It also conducts insurance-related operations.
Directors
- Donald Horton CHM (71)
- David Auld CEO (65)
- Bill Wheat CFO (55)
- Michael Murray COO (55)
- Paul Romanowski COO (51)
- Barbara Allen IND (75)
- Bradley Anderson IND (60)
- Michael Buchanan IND (74)
- Benjamin Carson IND (70)
- Michael Hewatt IND (72)
- Maribess Miller IND (68)
- Last Annual
- September 30th, 2024
- Last Interim
- March 31st, 2025
- Incorporated
- July 1st, 1991
- Public Since
- June 5th, 1992
- No. of Shareholders
- 240
- No. of Employees
- 14,766
- Sector
- Homebuilding & Construction Supplies
- Industry
- Consumer Cyclicals
- Exchange
New York Stock Exchange- Shares in Issue
- 308,629,060
- Address
- 1341 Horton Circle, ARLINGTON, 76011
- Web
- https://www.drhorton.com/
- Phone
- +1 8173908200
- Contact
- Jessica Hansen
- Auditors
- Ernst & Young LLP
Upcoming Events for DHI
Q3 2025 DR Horton Inc Earnings Release
Similar to DHI
Acuity
New York Stock Exchange
Advanced Drainage Systems
New York Stock Exchange
Armstrong World Industries
New York Stock Exchange
Azek
New York Stock Exchange
Beazer Homes USA
New York Stock Exchange
FAQ
What is the DR Horton share price?
As of Today at 20:19 UTC, shares in DR Horton are trading at $121.25. This share price information is delayed by 15 minutes.
How has the DR Horton share price performed this year?
Shares in DR Horton last closed at $121.25 and the price had moved by -16.8% over the past 365 days. In terms of relative price strength the DR Horton share price has underperformed the S&P500 Index by -21.77% over the past year.
What are the analyst and broker recommendations for DR Horton?
The overall consensus recommendation for DR Horton is Hold. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the DR Horton dividend yield?
The DR Horton dividend yield is 1.15% based on the trailing twelve month period.
Does DR Horton pay a dividend?
Last year, DR Horton paid a total dividend of $1.40, and it currently has a trailing dividend yield of 1.15%.Looking ahead, shares in DR Horton are due to go ex-dividend on 2025-05-02 and the next dividend pay date is 2025-05-09.
When does DR Horton next pay dividends?
DR Horton are due to go ex-dividend on 2025-05-02 and the next dividend pay date is 2025-05-09. The historic dividend yield on DR Horton shares is currently 1.15%.
How do I buy DR Horton shares?
To buy shares in DR Horton you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of DR Horton?
As of the previous close price of $121.25, shares in DR Horton had a market capitalisation of $37.42bn.
Where are DR Horton shares listed?
Here are the trading details for DR Horton:
- Country of listing: United States
- Exchange: NYQ
- Ticker Symbol: DHI
What kind of share is DR Horton?
Based on an overall assessment of its quality, value and momentum DR Horton is currently classified as a Contrarian. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a DR Horton share price forecast for 2025?
The analyst consensus target price for shares in DR Horton is $156.08. That is 28.73% above the last closing price of $121.25.
Analysts covering DR Horton currently have a consensus Earnings Per Share (EPS) forecast of $12.22 for the next financial year.
Find out moreWhat is the trend in the DR Horton share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like DR Horton. Over the past six months, its share price has underperformed the S&P500 Index by -30.94%.
As of the last closing price of $121.25, shares in DR Horton were trading -22.85% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the DR Horton PE Ratio?
The DR Horton PE ratio based on its reported earnings over the past 12 months is 9.39. The shares last closed at $121.25.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of DR Horton?
DR Horton's management team is headed by:
- Donald Horton - CHM
- David Auld - CEO
- Bill Wheat - CFO
- Michael Murray - COO
- Paul Romanowski - COO
- Barbara Allen - IND
- Bradley Anderson - IND
- Michael Buchanan - IND
- Benjamin Carson - IND
- Michael Hewatt - IND
- Maribess Miller - IND